BioLineRx
BLRX
#9532
Rank
S$39.76 M
Marketcap
$0.37
Share price
-14.30%
Change (1 day)
-81.26%
Change (1 year)

P/E ratio for BioLineRx (BLRX)

P/E ratio as of November 2024 (TTM): -0.2997

According to BioLineRx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.299667. At the end of 2022 the company had a P/E ratio of -1.31.

P/E ratio history for BioLineRx from 2011 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-1.31-60.27%
2021-3.30132.94%
2020-1.4257.07%
2019-0.9020-62.12%
2018-2.38-41.02%
2017-4.0422.87%
2016-3.29-28.68%
2015-4.61-6.2%
2014-4.9133.8%
2013-3.6766.86%
2012-2.20-25.24%
2011-2.94

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.